Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 3
1994 1
1996 2
1997 1
1998 3
1999 2
2000 2
2001 2
2002 2
2003 2
2004 14
2005 10
2006 4
2007 15
2008 12
2009 8
2010 7
2011 6
2012 7
2013 3
2014 6
2015 9
2016 5
2017 1
2018 3
2019 5
2020 4
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

126 results
Results by year
Filters applied: . Clear all
Page 1
Kidney stones and the ketogenic diet: risk factors and prevention.
Sampath A, Kossoff EH, Furth SL, Pyzik PL, Vining EP. Sampath A, et al. J Child Neurol. 2007 Apr;22(4):375-8. doi: 10.1177/0883073807301926. J Child Neurol. 2007. PMID: 17621514 Clinical Trial.
The prevalence of kidney stones did not correlate with younger age or use of carbonic anhydrate inhibitors (eg, topiramate or zonisamide) but trended toward higher correlation with the presence of hypercalciuria (92% vs 71%, P = .08). ...
The prevalence of kidney stones did not correlate with younger age or use of carbonic anhydrate inhibitors (eg, topiramate or zonisamide
Therapeutic Drug Monitoring of Newer Antiepileptic Drugs: A Randomized Trial for Dosage Adjustment.
Aícua-Rapún I, André P, Rossetti AO, Ryvlin P, Hottinger AF, Decosterd LA, Buclin T, Novy J. Aícua-Rapún I, et al. Ann Neurol. 2020 Jan;87(1):22-29. doi: 10.1002/ana.25641. Epub 2019 Nov 26. Ann Neurol. 2020. PMID: 31714640 Clinical Trial.
METHODS: We performed a randomized, controlled trial comparing systematic with rescue TDM of lamotrigine, levetiracetam, oxcarbazepine, topiramate, brivaracetam, zonisamide, or pregabalin. Participants were adults with epilepsy, in whom treatment with newer generation AEDs …
METHODS: We performed a randomized, controlled trial comparing systematic with rescue TDM of lamotrigine, levetiracetam, oxcarbazepine, topi …
Clinical pharmacology and therapeutic drug monitoring of zonisamide.
Mimaki T. Mimaki T. Ther Drug Monit. 1998 Dec;20(6):593-7. doi: 10.1097/00007691-199812000-00001. Ther Drug Monit. 1998. PMID: 9853971 Review.
Zonisamide (1,2-benzisoxazole-3-methanesulfonamide) is a new antiepileptic drug developed in Japan. ...Concurrent enzyme-inducing anticonvulsants such as phenytoin, carbamazepine, or barbiturates stimulate zonisamide metabolism and decrease serum zonisamide l
Zonisamide (1,2-benzisoxazole-3-methanesulfonamide) is a new antiepileptic drug developed in Japan. ...Concurrent enzyme-inducing ant
Effect of zonisamide on parkinsonism in patients with dementia with Lewy bodies: A phase 3 randomized clinical trial.
Murata M, Odawara T, Hasegawa K, Kajiwara R, Takeuchi H, Tagawa M, Kosaka K. Murata M, et al. Parkinsonism Relat Disord. 2020 Jul;76:91-97. doi: 10.1016/j.parkreldis.2019.12.005. Epub 2019 Dec 12. Parkinsonism Relat Disord. 2020. PMID: 31982288 Free article. Clinical Trial.
INTRODUCTION: Zonisamide is approved in Japan for treating motor dysfunction in Parkinson's disease, and might also be effective for parkinsonism in patients with dementia with Lewy bodies (DLB). ...The primary endpoint was the change in Unified Parkinson's D …
INTRODUCTION: Zonisamide is approved in Japan for treating motor dysfunction in Parkinson's disease, and might also be effecti …
Zonisamide, topiramate, and levetiracetam: efficacy and neuropsychological effects in alcohol use disorders.
Knapp CM, Ciraulo DA, Sarid-Segal O, Richardson MA, Devine E, Streeter CC, Oscar-Berman M, Surprise C, Colaneri L, Putnam M, Waters M, Richambault C. Knapp CM, et al. J Clin Psychopharmacol. 2015 Feb;35(1):34-42. doi: 10.1097/JCP.0000000000000246. J Clin Psychopharmacol. 2015. PMID: 25427171 Free PMC article. Clinical Trial.
This study evaluated the effects of zonisamide (400 mg/d) on alcohol consumption and its neurotoxic effects in subjects with AD. ...These findings indicate that zonisamide may have efficacy in the treatment of AD, with effect sizes similar to topiramate. ...
This study evaluated the effects of zonisamide (400 mg/d) on alcohol consumption and its neurotoxic effects in subjects with AD. ...T …
Zonisamide as adjunctive therapy for refractory partial seizures.
Brodie MJ. Brodie MJ. Epilepsy Res. 2006 Feb;68 Suppl 2:S11-6. doi: 10.1016/j.eplepsyres.2005.11.005. Epub 2005 Nov 28. Epilepsy Res. 2006. PMID: 16316744 Review.
Zonisamide (Zonegran) has been used extensively worldwide (>2 million patient-years experience) for the effective treatment of a broad range of epilepsy indications. Four randomised, placebo-controlled trials (duration <or=6 months) in the United States and Europe (8
Zonisamide (Zonegran) has been used extensively worldwide (>2 million patient-years experience) for the effective treatment of a b
Open label trial of the tolerability and efficacy of zonisamide in the treatment of alcohol dependence.
Knapp CM, Sarid-Segal O, Richardson MA, Colaneri LS, Afshar M, Devine E, Streeter CC, Piechniczek-Buczek J, Ciraulo DA. Knapp CM, et al. Am J Drug Alcohol Abuse. 2010 Mar;36(2):102-5. doi: 10.3109/00952991003674812. Am J Drug Alcohol Abuse. 2010. PMID: 20337506 Free PMC article. Clinical Trial.
Performances on the COWAT and on the DSMT were not significantly reduced by zonisamide treatment. Overall, zonisamide was well tolerated by the study subjects. CONCLUSION: These results indicate that zonisamide administration may not impair verbal fluency in …
Performances on the COWAT and on the DSMT were not significantly reduced by zonisamide treatment. Overall, zonisamide was well …
Placebo-controlled trial of zonisamide for the treatment of alcohol dependence.
Arias AJ, Feinn R, Oncken C, Covault J, Kranzler HR. Arias AJ, et al. J Clin Psychopharmacol. 2010 Jun;30(3):318-22. doi: 10.1097/JCP.0b013e3181db38bb. J Clin Psychopharmacol. 2010. PMID: 20473070 Free PMC article. Clinical Trial.
INTRODUCTION: Zonisamide is an anticonvulsant medication with GABAergic, glutamatergic, and monoaminergic effects. Zonisamide has also been shown to reduce alcohol intake in rodents and in risky drinkers in the context of a laboratory study. ...
INTRODUCTION: Zonisamide is an anticonvulsant medication with GABAergic, glutamatergic, and monoaminergic effects. Zonisamide
Zonisamide as an Adjunctive Treatment to Cognitive Processing Therapy for Veterans With Posttraumatic Stress Disorder and Comorbid Alcohol Use Disorder: A Pilot Study.
Petrakis I, Ralevski E, Arias AJ, DeNegre D, Newcomb J, Gianoli M, McCarthy E, Meshberg-Cohen S, Yoon G. Petrakis I, et al. Am J Addict. 2020 Nov;29(6):515-524. doi: 10.1111/ajad.13061. Epub 2020 May 27. Am J Addict. 2020. PMID: 32462773 Clinical Trial.
Ideally, treatment for comorbidity should address both disorders simultaneously. Zonisamide, an anticonvulsant, may be effective in decreasing alcohol use and may attenuate symptoms of PTSD. ...Exploratory analysis of comparison of groups suggests there was no advantage of …
Ideally, treatment for comorbidity should address both disorders simultaneously. Zonisamide, an anticonvulsant, may be effective in d …
A randomized, controlled, double-blind, crossover trial of zonisamide in myoclonus-dystonia.
Hainque E, Vidailhet M, Cozic N, Charbonnier-Beaupel F, Thobois S, Tranchant C, Brochard V, Glibert G, Drapier S, Mutez E, Doe De Maindreville A, Lebouvier T, Hubsch C, Degos B, Bonnet C, Grabli D, Legrand AP, Méneret A, Azulay JP, Bissery A, Zahr N, Clot F, Mallet A, Dupont S, Apartis E, Corvol JC, Roze E. Hainque E, et al. Neurology. 2016 May 3;86(18):1729-35. doi: 10.1212/WNL.0000000000002631. Epub 2016 Apr 6. Neurology. 2016. PMID: 27053715 Clinical Trial.
OBJECTIVE: To evaluate the efficacy and safety of zonisamide in patients with myoclonus-dystonia. METHODS: We conducted a randomized, double-blind, placebo-controlled crossover trial of zonisamide (300 mg/d) in 24 patients with myoclonus-dystonia. ...Zonisamide
OBJECTIVE: To evaluate the efficacy and safety of zonisamide in patients with myoclonus-dystonia. METHODS: We conducted a randomized, …
126 results